T Cell News and Research

Latest T Cell News and Research

Researcher explores new way to deliver therapy to brain metastases from primary breast cancer

Researcher explores new way to deliver therapy to brain metastases from primary breast cancer

Ribavirin, interferon-alpha 2b inhibit virus replication in cell culture, NIH study finds

Ribavirin, interferon-alpha 2b inhibit virus replication in cell culture, NIH study finds

Researchers study new ways of taking advantage of caffeine's lethal effects on cancer cells

Researchers study new ways of taking advantage of caffeine's lethal effects on cancer cells

Study highlights how genes can acquire, adapt to different roles in human evolution

Study highlights how genes can acquire, adapt to different roles in human evolution

FDA approval paves way for U-M to conduct Phase II trial of stem cell injections in ALS patients

FDA approval paves way for U-M to conduct Phase II trial of stem cell injections in ALS patients

Researchers propose strategies for improving the anti-cancer effects of interferon

Researchers propose strategies for improving the anti-cancer effects of interferon

Study: Shock wave-facilitated cell therapy improves outcomes in patients with chronic heart failure

Study: Shock wave-facilitated cell therapy improves outcomes in patients with chronic heart failure

NCI investigators design genetically engineered mouse to study human lung squamous cell carcinoma

NCI investigators design genetically engineered mouse to study human lung squamous cell carcinoma

Fully-retractable embolization coil introduced by Cook Medical

Fully-retractable embolization coil introduced by Cook Medical

New combination therapies with anti-sickling capabilities needed for sickle cell disease

New combination therapies with anti-sickling capabilities needed for sickle cell disease

CRISPR helps some bacteria evade mammalian immune system

CRISPR helps some bacteria evade mammalian immune system

Mast Therapeutics' data show that MST-188 reduces aggregation of both older and younger RBC

Mast Therapeutics' data show that MST-188 reduces aggregation of both older and younger RBC

Preclinical studies show bladder cancers, mesotheliomas respond to treatment with ADI-PEG 20

Preclinical studies show bladder cancers, mesotheliomas respond to treatment with ADI-PEG 20

NCI researchers overcome major impediment to development of effective stem cell therapies

NCI researchers overcome major impediment to development of effective stem cell therapies

Scientists reveal that stem cells, tissue-specific cells can be grown from mature mammalian cells

Scientists reveal that stem cells, tissue-specific cells can be grown from mature mammalian cells

UTHealth neuroscientists demonstrate new strategy to overcome memory deficits

UTHealth neuroscientists demonstrate new strategy to overcome memory deficits

Findings hold promise for development of therapies to fight different viral infections

Findings hold promise for development of therapies to fight different viral infections

UTMB researchers identify protein that can interfere with the brain's response to leptin

UTMB researchers identify protein that can interfere with the brain's response to leptin

New research sheds light on successful ovulation and fertilization

New research sheds light on successful ovulation and fertilization

New pre-clinical study suggests novel drug combination therapy for leukemia treatment

New pre-clinical study suggests novel drug combination therapy for leukemia treatment

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.